Checkmate Pharmaceuticals financials at a glance
| Year | Year | 2020 | 2021 | 2022 | 2019 | 2023 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-3.64 | $-2.84 | $0.00 | ||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | 0 | 0 | 0 |
| Sha. | Shares |
|
21.55m | 21.63m | 21.63m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$-38.11M | $-53.72M | $0.00M | $-26.85M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $-54.56M | $0.00M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-3.99 | $-2.52 | $0.00 | $-18.51 | $0.00 |